CLINICAL_TRIALS
trial_result
· 2012-05-04
Clinical Trial Update: RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes [Phase 2]
Summary
Phase 2 clinical trial evaluating everolimus (RAD001) in patients with myelodysplastic syndromes was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Case Comprehensive Cancer Center | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED | Results posted: 2012-05-04